Axogen Inc vs MasterCard Inc — how do they compare? Axogen Inc trades at $38.74 (market cap $2.06B), while MasterCard Inc trades at $538 (market cap $475.39B). The key difference: MasterCard Inc is far larger — about 230.8× Axogen Inc's market cap, and MasterCard Inc pays a 0.65% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | MA | |
|---|---|---|
Market Cap | $2.06B | $475.39B |
Sector | Technology | Consumer Cyclical |
52-Week High | $46.19 | $598.96 |
52-Week Low | $11.28 | $471.55 |
Enterprise Value | $1.98B | $486.13B |
Volume | — | 4,635,698 |
Dividend Yield | — | 0.65% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Mastercard (MA) trades at $538.56, up 0.16% on the day, with a bullish technical signal and strong institutional buying interest. The stock exhibits robust fundamentals with revenue growing to $32.79B in 2025 and net income margin at 45.88%, supported by consistent earnings beats. Recent news highlights Mastercard's AI and digital payment initiatives, while analyst consensus remains strongly positive with a $634.27 price target.
Outlook remains favorable given earnings momentum and strategic positioning in digital payments, though high valuation multiples and competitive fintech disruption pose risks. Upside potential is supported by Wall Street's buy ratings and institutional accumulation, but investors should monitor payment industry evolution and interest rate sensitivity.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →